A Study of IDE849 in Patients With DLL3 Expressing Tumors Including Small Cell Lung Cancer
IDEAYA Biosciences
IDEAYA Biosciences
Molecular Partners AG
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
AbbVie
Phanes Therapeutics
Novelty Nobility, Inc.
Merck Sharp & Dohme LLC
Sichuan Baili Pharmaceutical Co., Ltd.
Hutchmed
Hansoh BioMedical R&D Company
Hoffmann-La Roche
Travera Inc
Xencor, Inc.
SpeciCare
Guangdong Zhongsheng Pharmaceutical Co., Ltd.
INSYS Therapeutics Inc
Novartis